Safety, Tolerability and Pharmacokinetics of ASM-024 Administered to Healthy Subjects and Subjects With Moderate Asthma

NCT01793298 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

55

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of efficacy

Conditions

Asthma

Interventions

DRUG: ASM-024

Sponsor

Asmacure Ltée